Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers
PHASE1CompletedINTERVENTIONAL
Enrollment
31
Participants
Timeline
Start Date
May 31, 2014
Primary Completion Date
May 31, 2014
Study Completion Date
May 31, 2014
Conditions
Healthy
Interventions
DRUG
DA-7218
DRUG
Placebo
Trial Locations (1)
Unknown
Seoul National University Hospital, Seoul
All Listed Sponsors
lead
Dong-A ST Co., Ltd.
INDUSTRY
NCT02097043 - Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter